| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |